Loratadine; Pseudoephedrine Sulfate Patent Expiration
Loratadine; Pseudoephedrine Sulfate was first introduced by Bayer Healthcare Llc
Loratadine; Pseudoephedrine Sulfate Patents
Given below is the list of patents protecting Loratadine; Pseudoephedrine Sulfate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Claritin-d 24 Hour |
US5314697 (Pediatric) | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
Apr 23, 2013
(Expired) | Bayer Healthcare Llc |
| Claritin-d 24 Hour | US5314697 | Stable extended release oral dosage composition comprising loratadine and pseudoephedrine |
Oct 23, 2012
(Expired) | Bayer Healthcare Llc |
Loratadine; Pseudoephedrine Sulfate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List